Lucy Therapeutics is providing effective treatments for neurological diseases that start with the mitochondria. Mitochondria are the powerhouse of the cell and are important for human health. Lucy believes that drivers of complex diseases lie within the mitochondria. By unraveling the biology of mitochondrial dysfunction, Lucy is identifying targets for disease disruption and diagnosis. Rather than focusing solely on genetics or single mitochondrial function, Lucy is exploring diverse diseases for the underlying biology that they share. Their lead program is for Parkinson’s disease with a general focus on diseases of the central nervous system.

Lucy Therapeutics

Founded: 2017
Location: Cambridge, MA
Employee range: 1 - 10
Clinical stage: RD
Therapy area: Parkinson&#x27;s
Drug types: NEU, GEN, PED
Lead product: Undisclosed
Funding: $4.9M grant Apr 2022

Drug notes:

About:

Jobs: